Postmenopausal women with osteoporosis may be associated with high endothelin-1

Gynecological Endocrinology

Volumn 25, Issue 10, 2009, Pages 674-678

  Gulhan, Ibrahim ^a   Kebapcilar, Levent ^a   Alacacioglu, Ahmet ^b   Bilgili, Sibel ^b   Kume, Tuncay ^c   Aytac, Bilal ^d   Gunaydin, Rezzan ^a  

^a Izmir Research and Training Hospital   (Turkey)

^b Izmir Research and Training Hospital ^*  (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d MINISTRY OF HEALTH   (Turkey)

Author keywords

Asymmetrical dimethyl arginine; Endothelin 1; Osteoporosis; Postmenopausal women

Indexed keywords

ENDOTHELIN 1; N(G),N(G) DIMETHYLARGININE;

ADULT; ARTICLE; BONE DENSITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM;

ARGININE; BONE DENSITY; CHI-SQUARE DISTRIBUTION; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; REGRESSION ANALYSIS;

EID: 70350681824     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590903015429     Document Type: Article

References (23)

1. von Schroeder HP, Veilette CJ, Payandeh J, Qureshi A, Heersche JN. Endothelin-1 promotes osteoprogenitor proliferation and differentiation in fetal rat calvarial cell cultures. Bone 2003;33:673-684.
2. Tatrai A, Stern PH. Endothelin-1 modulates calcium signaling by epidermal growth factor, alpha-thrombin, and prostaglandin E1 in UMR-106 osteoblastic cells. J Bone Miner Res 1993;8:943-952.
3. Windischhofer W, Zach D, Fauler G, Raspotnig G, Kofeler H, Leis HJ. Involvement of Rho and p38 MAPK in endotelin-1- induced expression of PGHS-2 mRNA in osteoblast-like cells. J Bone Miner Res 2002;17:1774-1784.
4. Hierl T, Borcsok I, Sommer U, Ziegler R, Kasperk C. Regulation of interleukin-6 expression in human osteoblastic cells in vitro. Exp Clin Endocrinol Diabetes 1998;106:324-333.
5. Helfrich MH, Evans DE, Grabowski PS, Pollock JS, Ohshima H, Ralston SH. Expression of nitric oxide synthase isoforms in bone and bone cell cultures. J Bone Miner Res 1997;12:1108-1115. (Pubitemid 27264225)
6. Hukkanen MV, Platts LAM, Fernandez de Marticorena I, et al. Developmental regulation of nitric oxide synthase expression in rat skeletal bone. J Bone Miner Res 1999;14: 868-877.
7. Lu R, Hu CP, Wu XP, Liao EY, Li YJ. Effect of age on bone mineral density and the serum concentration of endogenous nitric oxide synthase inhibitors in rats. Comp Med 2002;52: 224-228.
8. Peng WJ, Jiang JL, Jia SJ, Li D, Zhang XJ, Luo D, Liao EY, Deng HW, Li YJ. Asymmetric dimethylarginine is not involved in ovariectomy-induced osteopenia in rats. Comp Med 2005;55:30-33.
9. Muratli HH, Celebi L, Hapa O, Biçimoglu A. Comparison of plasma endothelin levels between osteoporotic, osteopenic and normal subjects. BMC Musculoskelet Disord 2005;6: 49.
10. Moldes O, Sobrino T, Millán M, Castellanos M, Pérez de la Ossa N, Leira R, Serena J, Vivancos J, Dávalos A, Castillo J. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t- PA. Stroke 2008;39:2006-2010.
11. Schulze F, Wesemann R, Scwedhelm E, Arakawa N, Sydow K, Albsmeier J, Ooke JP, Boger RH. Determination of asymmetric dimethylarginine (ADMA) sing a novel ELISA assay. Clin Chem Lab Med 2004;42:1377-1383.
12. Schulze F, Maas R, Freese R, Schwedhelm E, Simberhorn E, Boger RH. Determination of a reference value for NG, NGdimethyl- L-arginine in 500 subjects. Eur J Clin Invest 2005;35:622-626.
13. Alam AS, Gallagher A, Shankar V, Ghatei MA, Datta HK, Huang CL, Moonga BS, Chambers TJ, Bloom SR, Zaidi M. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption. Endocrinology 1992;130:3617-3624.
14. Zaidi M, Alam AS, Bax BE, Shankar VS, Bax CM, Gill JS, Pazianas M, Huang CL, Sahinoglu T,Moonga BS. Role of the endothelial cell in osteoclast control: new perspectives. Bone 1993;14:97-102.
15. Haenggi W, Bersinger NA, Mueller MD, Birkhaeuser MH. Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone. Gynecol Endocrinol 1999;13:202-205.
16. Altavilla D, Crisafulli A, Marini H, Esposito M, D'Anna R, Corrado F, Bitto A, Squadrito F. Cardiovascular effects of the phytoestrogen genistein. Curr Med Chem Cardiovasc Hematol Agents 2004;2:179-186.
17. Takuwa Y, Ohue Y, Takuwa N, Yamashita K. Endothelin-1 activates phospholipase C and mobilizes Ca from extra and intracellular pools in osteoblastic cells. Am J Physiol 1989;257:E797-E803.
18. Kasperk CH, Borcsok I, Schairer HU, Schneider U, Nawroth PP, Niethard FU, Ziegler R. Endothelin-1 is a potent regulator of human bone cell metabolism in vitro. Calcif Tissue Int 1997;60:368-374. (Pubitemid 27143452)
19. Leis HJ, Zach D, Huber E, Windischhofer W. Prostaglandin endoperoxide synthase-2 contributes to the endothelin/sarafotoxin- induced prostaglandin E2 synthesis in mouse osteoblastic cells (MC3T3-El): evidence for a protein tyrosine kinase-signaling pathway and involvement of protein kinase C. Endocrinology 1998;139:1269-1277.
20. von der Recke P, Hansen MA, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999;106:273-278.
21. Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 1998;62:209-213.
22. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PW. Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study. Calcif Tissue Int 2001;68:271-276.
23. Armour KE, Armour KJ, Gallagher ME, Godecke A, Helfrich MH, Reid DM, Ralston SH. Defective bone formation and anabolic responses to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide sythase. Endocrinology 2001;142:760-766.